• Verbascoside PKC/NF-κB Workflow Guide

  2026-08-25

  Verbascoside provides a practical small-molecule approach for probing PKC/NF-κB control of RANKL-induced osteoclast differentiation and inflammatory signaling. This guide connects concentration-response design, orthogonal pathway readouts, and a carefully bounded extension to trigeminal inflammation research.

• (S)-(+)-Dimethindene maleate: M2 Workflow

  2026-08-25

  (S)-(+)-Dimethindene maleate (SKU B6734) provides a research tool for examining M2 muscarinic receptor antagonism while accounting for concurrent histamine H1 receptor activity. This article outlines practical handling, assay setup, and QC considerations for autonomic regulation, cardiovascular physiology, and respiratory system function research; it is not intended for diagnostic or medical use.

• MK-0812 Workflow for CCR2 Studies in MASH

  2026-08-24

  Build a rigorous CCR2 blockade workflow around MK-0812 to distinguish monocyte recruitment from gut-barrier, microbiota, and lipid-signaling effects in MASH models. The approach combines whole-blood pharmacology, flow cytometry, tissue endpoints, and gut–liver-axis controls for more interpretable inflammation studies.

• CCK-8, Endogenous Opioids, and Morphine Withdrawal Anxiety

  2026-08-24

  This 2014 Neuroscience study identifies a previously underdefined role for cholecystokinin octapeptide (CCK-8) in reducing anxiety-like behavior during morphine withdrawal. Pharmacological blockade experiments indicate that the effect depends on central CCK1 receptor activity and endogenous μ-opioid signaling, highlighting a mechanistic direction for opioid addiction and withdrawal studies.

• 2X Taq PCR Master Mix for Reliable DNA Amplification

  2026-08-23

  2X Taq PCR Master Mix (with dye) combines recombinant Taq DNA polymerase with integrated gel-loading dye for streamlined polymerase chain reaction workflows. Its adenine-overhang chemistry supports TA cloning, while the formulation is designed for routine genotyping, cloning, and DNA sequence analysis.

• Candida auris Antifungal Pipeline: Systematic Review

  2026-08-22

  This systematic review maps 12 investigational antifungals against multidrug-resistant Candida auris, integrating susceptibility data with evidence from neutropenic animal models. Its main practical contribution is a structured comparison of emerging agents while showing why promising MIC values and survival benefits still require validation in standardized studies and clinical populations.

• Ribonuclease R Workflow for Circular RNA in Pulpitis

  2026-08-21

  Use Ribonuclease R to reduce linear-RNA background and strengthen circular RNA validation in inflammation and DNA-damage studies. This workflow connects RNase R-resistant transcript enrichment with qRT-PCR, localization, pulldown, and pathway assays inspired by recent pulpitis research.

• Pterostilbene Preserves Mitochondrial Quality in Dermal Agin

  2026-08-21

  Zhou et al. show that pterostilbene reduces senescence phenotypes in human dermal fibroblasts exposed to UVB-associated oxidative stress or replicative aging. The study links these effects to improved mitochondrial morphology, respiration, and mitophagy, while mouse experiments provide preliminary tissue-level support for a mitochondrial quality-control mechanism in skin aging.

• AMG 9810: TRPV1 Signaling Under Stress

  2026-08-20

  A translational framework for using AMG 9810 to dissect TRPV1-dependent sensory signaling while incorporating metabolic and lysosomal stress as experimental context rather than assumed mechanism.

• MK-0812 and the Gut–Liver Inflammation Axis

  2026-08-20

  A translational framework for using MK-0812 to test whether CCR2-dependent monocyte trafficking connects intestinal TM6SF2 loss, gut–liver signaling, and MASH-associated inflammation.

• Cdc42–GSK-3β/β-Catenin Signaling in Kidney Fibrosis

  2026-08-19

  The 2024 Advanced Science study identified daphnepedunin A, a natural diterpenoid from Wikstroemia chamaedaphne, as an anti-fibrotic lead that directly targets Cdc42. By reducing Cdc42 activity and disrupting the PKCζ/GSK-3β/β-catenin axis, the compound promoted β-catenin degradation and attenuated renal fibrosis in cell and unilateral ureteral obstruction models.

• Influenza Hemagglutinin (HA) Peptide in EV Assays

  2026-08-19

  Influenza Hemagglutinin (HA) Peptide is more than a detection reagent: it can be used to design cleaner capture, competition, and elution experiments. This guide connects HA-tag workflow decisions with mechanistic lessons from RAB31-controlled exosome biology.

• Intestinal TM6SF2 and the Gut–Liver Axis in MASH

  2026-08-18

  The 2025 Nature Metabolism study identifies intestinal TM6SF2 as a protective regulator of the gut–liver axis, linking epithelial lipid handling to barrier integrity, microbial dysbiosis, lysophosphatidic acid signaling and MASH. Its conditional knockout, fecal-transfer, co-housing and pharmacological experiments provide a framework for distinguishing intestine-initiated mechanisms from liver-intrinsic disease processes.

• Angiotensin II: From GPCR Signal to AAA Strategy

  2026-08-18

  A translational framework for using Angiotensin II as a mechanistically defined vascular stressor, connecting receptor signaling and oxidative stress to hypertension, remodeling, and abdominal aortic aneurysm research while clarifying how targeted delivery strategies may improve therapeutic translation.

• Naloxone Hydrochloride for Cell Assay Reliability

  2026-08-17

  Learn how Naloxone hydrochloride, SKU B8208, can support controlled cell viability, proliferation, and cytotoxicity experiments through defined receptor biology, practical solubility, and documented purity. This scenario-based guide addresses stock preparation, assay controls, interpretation, and evidence-based product selection.

8066 records 1/538 page Next 12345 下5页 Last page